Français

Topic: Member Marathon

Speakers:

MIDI Medical Product Development

MIDI is an award-winning strategic turnkey, FDA and ISO compliant product development consulting firm with over 50 years of experience servicing domestic and international clientele representing medical, life sciences and home healthcare markets. Our multi-disciplined, talented group achieves innovative results within rapid timelines under stringent regulatory constraints. MIDI's dedicated teams of research, design and engineering professionals offer a unique combination of talent and experience, consisting of key personnel working together with a record of outstanding achievement in developing Class I, II, and III products. Our proprietary DevelopmentDNA™ approach to product development provides clients with a distinguished thoroughness in securing product results that answer market needs and increase sales as well as market share.

Idorsia

Idorsia is specialized in the discovery, development, and commercialization of innovative medicines, with the aim of transforming the horizon of therapeutic options. We have a diversified and balanced portfolio, comprising assets developed and/or marketed by Idorsia and assets that are partner-led to maximize the value we have created. Our drug discovery engine has produced innovative drugs with the potential to transform the treatment paradigm in multiple therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. The company also has a vaccine platform for the discovery and development of glycoconjugate vaccines containing synthetic antigenic glycan molecules, with or without a carrier protein, to prevent infection. Our portfolio includes products on or close to the market – QUVIVIQ™ (daridorexant) and TRYVIO™/JERAYGO™ (aprocitentan) – and assets at various stages of clinical development.

Kye Pharmaceuticals

Kye is a growth-stage, specialty pharmaceutical company committed to bringing value to Canadians by identifying, licensing, and commercializing novel prescription medicines. With a growing pipeline of innovative medicines, Kye’s portfolio spans a range of therapeutic areas including cardiology, psychiatry, pediatrics, rare diseases, hematology, and neurology. Our dedicated and experienced team perseveres to source marketed medicines from around the world that satisfy the unmet needs of Canadians. Currently, we are fiercely focused on supporting our treatments for attention deficit hyperactivity disorder (ADHD), Lambert-Eaton Myasthenic Syndrome (LEMS), symptomatic treatment of stable angina, major depressive disorder (MDD), and mild to moderate anemia. In addition to our current portfolio, we are very active in business development and plan to introduce many more innovative products in the years ahead.  Whether navigating marketing authorizations, tailoring commercialization strategies, or rethinking the business from the patient’s point of view, our goal is to support the health of Canadian patients and their families with medicines that matter.

Corporate Traveller

Corporate Traveller is a travel management company under the umbrella of Flight Centre Travel Group (FCTG). With more than 25 years of experience working with Canadian businesses, our travel management services include dedicated travel consultants, user-friendly travel technology, and a commitment to white-glove service and the support you need. Our dedicated travel consultants deliver a seamless booking experience and ensure your business travel feels hassle-free, and your costs stay under budget. Our travel platform Melon gives you flexibility to book, access reports, monitor traveller safety, and have full visibility of your travel program. Our goal is to help Life Science Ontario members get the most out of their travel program while supporting travellers and their business goals.

 

TIME: 8:30-9:30am ET

 

Sponsored by:

 

LSO Knowledge and Networking Breakfast - November 21st - Virtual

  • Thursday Nov 21 2024, 8:30 AM - 9:30 AM
  • Online
    Toronto, Ontario
    Canada